Bacterial rRNA A-site recognition by DAPI: Signatures of intercalative binding

Preethi Parameswaran1, Yashaswina Arora1, Rajesh Patidar1

  • 1Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research-Raebareli, New Transit Campus, Lucknow, Uttar Pradesh 226002, India.

Biophysical Chemistry
|April 26, 2021
PubMed
Summary

Bisamidines, like DAPI, show potential for targeting bacterial A-site RNA, crucial for developing new antibacterials. These compounds exhibit strong binding and base-stacking interactions, offering a promising avenue for novel drug development.

Related Concept Videos